Chemical Structure : T-025
CAS No.: 2407433-00-3
货号: PC-35047Not For Human Use, Lab Use Only.
T-025 (T025, CLK inhibitor T-025) is an orally available, potent inhibitor of Cdc2-like kinases (CLKs) with Kd of 4.8, 0.096, 6.5, and 0.61 nM for CLK1, CLK2, CLK3, and CLK4, also inhibits DYRK1A and DYRK1B with IC50 of 0.074 and 1.5 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥1980 | In stock | |
5 mg | ¥2980 | In stock | |
10 mg | ¥4580 | In stock | |
25 mg | ¥7580 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
T-025 (T025, CLK inhibitor T-025) is an orally available, potent inhibitor of Cdc2-like kinases (CLKs) with Kd of 4.8, 0.096, 6.5, and 0.61 nM for CLK1, CLK2, CLK3, and CLK4, also inhibits DYRK1A and DYRK1B with IC50 of 0.074 and 1.5 nM.
T-025 (T025, CLK inhibitor T-025) reduces CLK-dependent phosphorylation, induces skipping exon, resulting in anti-proliferative effect in MDA-MB-468 in vitro and in vivo accompanied by the modulation of pre-mRNA splicing.
T-025 (T025, CLK inhibitor T-025) shows sensitivity against high CLK2 expression or MYC amplification cancer celles.
T-025 (T025, CLK inhibitor T-025) exhibits significant anti-tumor efficacy in MYC-driven breast tumor allograft models.
分子量 | 382.431 | |
分子式 | C21H18N8 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N2-methyl-N4-(pyrimidin-2-ylmethyl)-5-(quinolin-6-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine |
1. Iwai K, et al. EMBO Mol Med. 2018 May 16. pii: e8289.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright